Join the Master in Law program for a panel discussion on the legal disputes surrounding patent ownership of CRISPR technology, a groundbreaking tool that enables gene editing to correct genetic defects, treat and prevent disease, and improve crops.

Using the example of a current vaccine that was developed with CRISPR technology, our panel of experts will explain the patent and licensing process and the ongoing court battles over ownership of CRISPR patents.

Panelists include:

• Penn Geneticist, Cardiologist, Faculty, and Co-Founder and Senior Scientific Advisor of Verve Therapeutics, Kiran Musunuru, MD (ML ’19)
• Hon. Leonard P. Stark, Judge, U.S. Court of Appeals for the Federal Circuit
• Michael A. Fitts Professor of Law, Author and Intellectual Property expert R. Polk Wagner

Reception to follow.

REGISTER

This program has been approved for 1 Substantive CLE credit for Pennsylvania lawyers. CLE credit may be available in other jurisdictions as well. Attendees seeking CLE credit can make a payment via cash or check made payable to The Trustees of the University of Pennsylvania on the day of the event or prior to the event via the online registration link in the amount of $40.00 ($20.00 public interest/non-profit attorneys). In order to receive the appropriate amount of credit, passwords provided throughout the program must be noted in your evaluation form.

Penn Carey Law Alumni receive CLE credits free through The W.P. Carey Foundation’s generous commitment to Lifelong Learning.